STRONG STAR consortium advances PTSD treatment for soldiers
The STRONG STAR consortium, based at the University of Texas Health Science Center in San Antonio, is at the forefront…
Тэг: clinical trials
High Placebo Response Challenges ADHD Medication Development
Recent research highlights a significant placebo response in patients with Attention Deficit Hyperactivity Disorder (ADHD), raising concerns for the development…
MindMed advances LSD therapy for anxiety disorder trials
MindMed (MNMD) is leading innovative research into psychedelic-assisted therapies and is now progressing to Phase 3 clinical trials for its…
Lawmaker proposes bill for ibogaine trials to treat PTSD, addiction
A Mississippi lawmaker plans to introduce a bill aimed at initiating clinical trials for ibogaine, a psychedelic drug that some…
Silo Pharma initiates key trials for PTSD nasal therapy
Silo Pharma, Inc. (NASDAQ:SILO), based in Sarasota, Florida, is advancing its research on a new intranasal therapy aimed at treating…
Silo Pharma’s PTSD Drug SPC-15 Advances to Human Trials
Silo Pharma, a biopharmaceutical company focused on developing treatments for mental health disorders, has taken a significant step forward in…
Helix Clinical Research і Southern Illinois Associates пачынаюць выпрабаванні ў галіне псіхічнага здароўя
Клінічныя даследаванні Helix абвясцілі аб партнёрстве з Southern Illinois Associates для пашырэння клінічных выпрабаванняў у галіне псіхічнага здароўя ў сталічным...
MindMed begins Phase 3 trials of LSD-based treatment for anxiety
MindMed, a U.S.-based pharmaceutical company, has initiated Phase 3 clinical trials for its LSD-based drug, MM120 (lysergide d-tartrate), targeting generalized…
Belarusian 
English 
French 
German 
Russian 
Spanish 
Ukrainian